sanhuangwuji powder + celecoxib + esomeprazole + methotrexate

This is a combination therapy consisting of four components: - **Sanhuangwuji powder**: A traditional Chinese medicine (TCM) herbal formulation, typically used for its anti-inflammatory and detoxifying properties. Its precise composition may vary, but it is commonly used in TCM for conditions involving inflammation and immune dysregulation. - **Celecoxib**: A selective nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase-2 (COX-2), reducing inflammation and pain. - **Esomeprazole**: A proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H+/K+ ATPase in gastric parietal cells, thereby protecting the gastrointestinal tract from NSAID-induced damage. - **Methotrexate**: An antimetabolite and disease-modifying antirheumatic drug (DMARD) that inhibits dihydrofolate reductase, interfering with DNA synthesis and immune cell proliferation. This combination has been studied primarily for the treatment of rheumatoid arthritis complicated by peptic ulcer. The rationale is to combine disease control (methotrexate), symptom relief (celecoxib), gastrointestinal protection (esomeprazole), and additional anti-inflammatory/immune-modulating effects from Sanhuangwuji powder. Clinical studies suggest this regimen improves both rheumatologic symptoms and peptic ulcer healing rates compared to standard therapies[1][2][3][8].